A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

NCT02685904 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Ankylosing Spondylitis

Interventions

BIOLOGICAL: ENIA11
BIOLOGICAL: Placebo

Sponsor

Mycenax Biotech Inc.

Collaborators

[object Object]